Citation Impact

Citing Papers

Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review
2008
Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee
2020 Standout
Analysis of initial poor graft function after orthotopic liver transplantation: experience of an australian single liver transplantation center
2002
Hepatocellular carcinoma
2003 Standout
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
2001 Standout
Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection
2016
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity
2020
Liver transplantation for cholangiocellular carcinoma: Analysis of a single-center experience and review of the literature
2001
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
2010 Standout
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
The effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal haemorrhage
1992
CLINICAL PRESENTATION AND OUTCOME OF TUBERCULOSIS IN KIDNEY, LIVER, AND HEART TRANSPLANT RECIPIENTS IN SPAIN1
1997
Systemic sclerosis
2017 Standout
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
Influence of donor criteria on postoperative graft function after orthotopic liver transplantation
1994
Management of Hepatocellular Carcinoma *
2005 Standout
Neuroendocrine gastrointestinal tumours
1996
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Nocardiosis at the Turn of the Century
2009 Standout
Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases
2019
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
One-Year Results with Extended-Release Tacrolimus/MMF, Tacrolimus/MMF and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
2007
Is Portal-systemic Shunt Worthwhile in Childʼs Class C Cirrhosis? Long-term Results of Emergency Shunt in 94 Patients With Bleeding Varices
1992
Glutathione peroxidase 4–regulated neutrophil ferroptosis induces systemic autoimmunity
2021
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Extended Resections for Hilar Cholangiocarcinoma
1999
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation
2006
Anti−IL-12/23 p40 antibody attenuates chronic graft-versus-host disease with lupus nephritis via inhibiting Tfh cell in mice
2020
Is Liver Transplantation Justified for the Treatment of Hepatic Malignancies?
1990
Liver Resection for Hilar and Peripheral Cholangiocarcinomas: A Study of 62 Cases
1998
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis
2006
Pancreatic islet transplantation after upper abdominal exeriteration and liver replacement
1990
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
2010 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Pediatric intestinal transplantation: Historical notes, principles and controversies
2002
Heart and lung transplantation in children
2006
Cholangiocarcinoma
2007 Standout
Nontuberculous Mycobacterial Infection in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
2004
Hepatic Resection and Transplantation for Peripheral Cholangiocarcinoma
1997
Prophylaxis Strategies for Solid‐Organ Transplantation
2001
IN VIVO EFFECT OF FK506 ON HUMAN PANCREATIC ISLETS
1991
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Immunotherapy in Elderly Transplant Recipients
2009
Infection in Organ-Transplant Recipients
1998 Standout
Cell migration, chimerism, and graft acceptance
1992 Standout
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
1993 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Infections in solid-organ transplant recipients
1997
Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?
1988
Surgical treatment of cholangiocellular carcinoma
1995
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Primary hepatic malignancy: The role of liver transplantation
1990
Effect of Impaired T Cell Receptor Signaling on the Gut Microbiota in a Mouse Model of Systemic Autoimmunity
2021 StandoutNobel
Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients
1991
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The many faces of multivisceral transplantation.
1991
Drugs for discoid lupus erythematosus
2017
Cardiac Allograft Vasculopathy
2008
Aspergillus fumigatusand Aspergillosis
1999 Standout
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
1992 StandoutScience
B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
2021 StandoutNobel
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Liver transplantation for hepatocellular carcinoma
1995
Indications for liver transplantation in hepatobiliary malignancy
1994
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts.
1990
Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation
2012
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout

Works of Robert Gordon being referenced

Mycobacterium tuberculosis after liver transplantation: Management and guidelines for prevention
1992
Abdominal Organ Cluster Transplantation for the Treatment of Upper Abdominal Malignancies
1989
Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant Recipients
2005
Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
2018
Explaining Variability in Mycophenolic Acid Exposure to Optimize Mycophenolate Mofetil Dosing
2006
Orthotopic Liver Transplantation for Alcoholic Liver Disease
1990
Retransplantation of the Liver
1985
Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Multiple Intravenous, Dose‐Ascending Study of Sirukumab in Cutaneous or Systemic Lupus Erythematosus
2013
Rankless by CCL
2026